Plain-English translation of NCT07370519 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This study is testing whether , a beneficial bacteria applied directly to the scalp, can help treat androgenetic alopecia (male and female pattern hair loss). Researchers believe that balancing the scalp's natural bacterial community might support hair follicle health and promote hair regrowth. You would receive the medication once daily for 12 months while researchers measure changes in your hair count, thickness, and quality.
Current hair loss treatments like minoxidil work for some people but not everyone, and researchers are looking for new approaches. This study explores whether targeting the scalp's microbiome—the community of beneficial bacteria living on your skin—might offer an alternative or additional treatment option for people struggling with hair loss.
You likely qualify if…
You likely don't qualify if…
You would visit the study center at baseline and then apply the medication to your scalp once daily at home for 12 months. Each day involves cleaning your scalp, applying the treatment with a cotton swab, and waiting at least 6 hours before washing your hair. You would return for follow-up visits where researchers measure your hair count per square centimeter, thickness, and overall hair quality to see whether the treatment helped.
AI-generated summary from trial data · Aug 24, 2026 · Not medical advice
China